Simon T Russell

Title: Simon T Russell: Innovator in Pharmaceutical Compounds

Introduction

Simon T Russell is a notable inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as angiotensin II antagonists. His work has implications for treating conditions such as hypertension and congestive heart failure.

Latest Patents

Simon T Russell holds 2 patents. His latest patents include "Quinoline derivatives and use thereof as angiotensin II antagonists." This invention concerns pharmaceutically useful novel compounds that are valuable in treating various medical conditions. The compounds are defined by a specific formula and include processes for their manufacture and medical application. Another significant patent is "Benz[4,5]imidazole-containing angiotensin antagonists." This invention also focuses on novel heterocyclic compounds that antagonize the actions of angiotensin II, providing therapeutic benefits for diseases such as hypertension.

Career Highlights

Throughout his career, Simon T Russell has worked with prominent companies, including Imperial Chemical Industries Limited and David A. Roberts. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Simon has collaborated with notable individuals in his field, including David A. Roberts and Robert J. Pearce. These collaborations have likely enhanced his research and development efforts.

Conclusion

Simon T Russell is a distinguished inventor whose work in pharmaceutical compounds has the potential to improve medical treatments for serious health conditions. His contributions to the field are noteworthy and continue to influence advancements in medicine.